CAPHOSOL Results In Minimal Oral Mucositis And Pain In Head/neck Cancer Patients New data show that CAPHOSOL® (www.cahttp://www.caphosol.comphosol.com), an advanced electrolyte solution, results in low rates of oral mucositis and pain in patients with head and neck (HN) cancer who are undergoing chemotherapy and radiation therapy.
Source: www.medicalnewstoday.comThe Nest Collective Announces Acquisition of Plum Organics The Nest Collective has added Plum Organics to its portfolio of consumer product brands with a focus on organic, healthy eating options for growing children. (PRWeb Feb 19, 2009)
Read the full story at http://www.prweb.com/releases/Nest_Collective/Organic_Baby_Food/prweb2097444.htm
Source: www.prweb.comBetter Outcomes In HIV-Infected Adults Treated Initially With Efavirenz-Based Therapies A study led by researchers at the Johns Hopkins Bloomberg School of Public Health found that HIV-infected patients taking the antiretroviral drug efavirenz were more likely to adhere to treatment and less likely to experience virologic failure and death compared to patients taking nevirapine. Nevirapine is the most frequently prescribed drug for patients undergoing highly active antiretroviral therapy (HAART) for the treatment of HIV/AIDS in sub-Saharan Africa, where the study was conducted.
Source: www.medicalnewstoday.comFDA advisory committee recommends approval for seizure treatment Sabril. FDA advisory committee recommends approval for seizure treatment Sabril. The Chicago Tribune (1/8, Japsen) reports, “Ovation Pharmaceuticals Inc. said Wednesday evening that an advisory committee to the U.S. Food and Drug Administration voted unanimously to recommend the company’s Sabril (vigabatrin) seizure treatment be approved by the agency.” The company “said Sabril was endorsed by the advisory [...]
Source: feeds.feedburner.comInfoMedics Survey Clearly Demonstrates Gap Between Doctors' Orders And Patient Prescription Behaviors InfoMedics, Inc., the patient feedback company, announced the results of a survey examining the behaviors of patients on
prescription medications. The findings show that a significant portion of medication users tend to ignore or stray from their doctor's orders, and that there are opportunities for improved patient-physician communication.
Source: www.medicalnewstoday.comGlobal Anti-Aging Products Market to Reach $291.9 Billion by 2015, According to New Report by Global Industry Analysts Anti-aging vitamins and supplements for health maintenance is a growing market fuelled by the aging population seeking to keep the dreaded signs of aging at bay. Scientific breakthroughs, technological improvements, aggressive marketing claims, coupled with rise in the number of younger consumers opting for skin treatments to preserve their youth will spark growth in worldwide anti-aging products to reach $291.9 billion by 2015. (PRWeb Feb 19, 2009)
Read the full story at http://www.prweb.com/releases/2009/02/prweb2021254.htm
Source: www.prweb.com
# posted by Network @ 4:33 PM